Allogene gives first look at an 'off the shelf' cell therapy for lymphoma

There is a noteworthy update this afternoon in the long-running effort to turn cells from healthy donors into effective cancer treatments — data suggesting an experimental therapy from Allogene Therapeutics may help very sick patients with non-Hodgkin lymphoma.